GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading platform for prescription savings in the U.S., today announced it will release its fourth quarter and full year 2025 ...
Analysts have recently evaluated GoodRx Holdings and provided 12-month price targets. The average target is $4.16, accompanied by a high estimate of $6.00 and a low estimate of $2.75. This current ...
Key Insights Significant control over GoodRx Holdings by individual investors implies that the general public has ...
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today released a new Weight Loss Medications Tracker that provides an inside look ...
Eligible patients can now get the Wegovy pill — the first oral GLP-1 treatment for weight management in adults — at Hy-Vee ...
LOS ANGELES, CALIFORNIA - APRIL 22: Gala Host/CTG Board Member Jana Bezdek (L) and Trevor Bezdek attend Center Theatre Group’s 2019 Gala “A Grand Night” at the Mark Taper Forum and Ahmanson Theatre on ...
Cheap prescription-drugs platform GoodRx is getting into the content business. The company is debuting GoodRx Health, a website that answers the most Googled questions about personal health. The move ...
GoodRx reports on tracking prescription fills for flu and COVID-19 treatments, revealing seasonal trends and insurance ...
GoodRx Holdings Inc.'s proposed $32 million settlement of a lawsuit alleging it illegally shared users’ data with Google LLC, Meta Platforms Inc., and Criteo Corp. failed to win approval from a ...
WASHINGTON -U.S. healthcare firm GoodRx Holdings has agreed to pay $1.5 million to settle allegations that it failed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results